Wolverine Trading, LLC Genprex, Inc. Call Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 23, 2023	BUY	$0.74 - $1.1 $7,992 - $11,880	10,800 New	10,800 $10,000
Q4 2022 Feb 14, 2023	SELL	$1.0 - $58.8 $22,700 - $1.33 Million	-22,700 Reduced 65.8%	11,800 $17,000
Q3 2022 Nov 14, 2022	BUY	$1.32 - $58.0 $45,540 - $2 Million	34,500 New	34,500 $48,000
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.31 $30,080 - $54,285	-23,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.82 - $3.5 $9,464 - $18,200	5,200 Added 28.42%	23,500 $54,000
Q4 2021 Feb 14, 2022	BUY	$1.21 - $2.7 $7,018 - $15,660	5,800 Added 46.4%	18,300 $24,000
Q3 2021 Nov 12, 2021	SELL	$2.59 - $3.36 $36,519 - $47,376	-14,100 Reduced 53.01%	12,500 $33,000
Q2 2021 Aug 06, 2021	BUY	$3.11 - $4.87 $10,574 - $16,558	3,400 Added 14.66%	26,600 $92,000
Q1 2021 May 14, 2021	BUY	$3.66 - $7.67 $84,912 - $177,944	23,200 New	23,200 $94,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $280M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.